Cargando…
Senolytics in a Model of Alzheimer's Disease
The therapeutic effects of senescent cell killing with senolytics in neurodegeneration mouse models poise this strategy as an intervention candidate for Alzheimer’s Disease (AD). However, it is unclear whether senolytic therapies for AD are translatable to human cells. To determine whether senolytic...
Autores principales: | Wang, Ellen, Lee, Suckwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680733/ http://dx.doi.org/10.1093/geroni/igab046.2420 |
Ejemplares similares
-
Senescence and Senolytics: State of the Art on Cellular Senescence, Senolytics, and Healthspan
por: Campisi, Judith
Publicado: (2020) -
Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer’s disease
por: Gonzales, Mitzi M., et al.
Publicado: (2023) -
Senolytics Reduce Coronavirus-Related Mortality in Old Mice
por: Camell, Christina
Publicado: (2021) -
Aging, Senescent Cells, and Senolytic Drugs: The Path to Translation
por: Kirkland, James
Publicado: (2020) -
Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018)